Cubist Systematic Strategies, LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2022$1,847,000
-23.2%
28,037
-41.1%
0.01%
-33.3%
Q2 2022$2,405,000
+19.7%
47,613
+51.4%
0.02%
-11.8%
Q1 2022$2,009,000
+115.6%
31,444
+261.5%
0.02%
+88.9%
Q4 2021$932,000
+1356.2%
8,699
+1296.3%
0.01%
+800.0%
Q3 2021$64,000
-98.0%
623
-98.3%
0.00%
-97.3%
Q2 2021$3,257,000
+143.2%
37,027
+168.8%
0.04%
+117.6%
Q1 2021$1,339,000
-66.1%
13,776
-60.8%
0.02%
-68.5%
Q4 2020$3,945,000
+1132.8%
35,178
+917.6%
0.05%
+980.0%
Q3 2020$320,000
+12.3%
3,457
-5.4%
0.01%0.0%
Q2 2020$285,000
-69.8%
3,656
-77.4%
0.01%
-80.8%
Q1 2020$944,000
-6.1%
16,150
+28.7%
0.03%
+44.4%
Q4 2019$1,005,000
+36.7%
12,548
+25.4%
0.02%
+20.0%
Q3 2019$735,000
+27.4%
10,008
+38.8%
0.02%
-21.1%
Q1 2019$577,000
+109.8%
7,212
+104.9%
0.02%
+26.7%
Q3 2018$275,000
+1427.8%
3,520
+1660.0%
0.02%
+1400.0%
Q1 2018$18,000
-79.5%
200
-82.9%
0.00%
-80.0%
Q4 2017$88,000
+2833.3%
1,172
+2447.8%
0.01%
Q3 2017$3,000
-92.9%
46
-94.5%
0.00%
-100.0%
Q2 2017$42,000
-61.5%
837
-69.4%
0.00%
-62.5%
Q1 2017$109,0002,7310.01%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders